CommercialCoverageHigh impact
State and School Employees' Health Insurance Plan - Injectable Oncology
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology·Medical Policy
We identified it
Jun 20, 2026
Summary
The State and School Employees' Health Insurance Plan has established new coverage criteria for injectable oncology medications under the medical benefit. The policy lists 47 specific oncology drugs with detailed approval requirements including FDA approval/compendia support, genetic testing when applicable, first-line therapy trials, and dosage limits, with 24 drugs specifically deemed not medically necessary due to available formulary alternatives.
Action Required
Immediately: Billing team must review all pending and future claims for the 47 listed injectable oncology drugs to ensure compliance with new coverage criteria. Verify patients meet ALL requirements including FDA approval/NCCN compendia support (Category 1 or 2A), completed genetic testing when applicable, documentation of first-line therapy failure or contraindications, and proper dosing. Flag the 24 drugs listed as 'not medically necessary' for denial as formulary alternatives exist. Update prior authorization processes to include 3-month approval for dose titration and 12-month approval for other requests.